An experimental gene therapy could offer new hope for patients living with retinitis pigmentosa, a group of inherited retinal diseases that can lead to progressive vision loss. Sulagna Bhattacharya, co founder and CEO of Nano Scope Therapeutics, shares how her own family’s experience with RP inspired her mission to develop new treatment options.
Bhattacharya explains why retinitis pigmentosa has been particularly challenging to treat. Because...
James Knightley, Chief International Economist for the U.S. at ING, joins Remy Blaire to dive into the recent Federal Reserve meeting, where new Fed...
Ray Salmond, head of markets at Cointelegraph, joins Remy Blaire to provide insights into the recent price action in the crypto markets, particularly Bitcoin....
The UAE is emerging as one of the world's most enthusiastic adopters of artificial intelligence, with utilization rates far exceeding the global average of...
Brian Jacobsen, Chief Economic Strategist at Annex Wealth Management, joins Remy Blaire to dive into the recent Federal Reserve meeting led by Kevin Warsh,...
Bryan Stirewalt executive advisor at Grant Thornton UAE and independent non-executive chairman of Julius Baer Middle East, sat down to address one of the...
Banking is undergoing one of the biggest transformations in its history as fintech, artificial intelligence, and digital platforms redefine how people access and use...